Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
Authors:
- Simon R. KnightSKSimon R. Knight
- Peter J. MorrisPMPeter J. Morris
- 15 October 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 90 (7) , 695-704
Abstract
Tuberculosis (TB) remains a leading cause of death in endemic countries and is 20 to 70 times more common in renal transplant recipients, where it contributes to both increased morbidity and mortality. This review will focus on the epidemiology of TB in renal transplant recipients and critically appraise the published literature on isoniazid prophylaxis in renal transplantation. A literature search for randomized and nonrandomized studies investigating the use of isoniazid prophylaxis in renal transplant recipients was conducted using Ovid MEDLINE, the Cochrane Library, the Transplant Library, and EMBASE. Relative risks (RRs) with 95% confidence intervals (CIs) are reported. Meta-analysis of the randomized controlled trials (RCTs) was performed with a fixed-effects model. Eleven relevant studies were identified; six nonrandomized and five RCTs. The nonrandomized studies indicate a reduced risk of TB with isoniazid prophylaxis. The RCTs demonstrated conflicting results, with two studies finding a reduction in TB with prophylaxis and two studies finding no difference. Meta-analysis of the 709 patients from the four RCTs demonstrated a reduced risk of TB with isoniazid prophylaxis (RR, 0.31; 95% CI, 0.19-0.51). No significant difference was found in the incidence of hepatitis (RR, 1.22; 95% CI, 0.91-1.65). Both randomized and nonrandomized studies support the value of isoniazid as TB prophylaxis in renal transplant recipients at risk of active infection. Clinicians should consider prophylaxis in renal transplant recipients in endemic areas or in recipients in nonendemic countries who are at risk. However, the evidence for the benefit of isoniazid prophylaxis in renal transplantation is not robust and there is still a need for a large multicenter trial of isoniazid prophylaxis in kidney transplantation in an endemic area.Keywords
This publication has 67 references indexed in Scilit:
- Mycobacterium tuberculosis in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2009
- Tuberculosis in liver transplant recipients: A systematic review and meta-analysis of individual patient dataLiver Transplantation, 2009
- Chronic Kidney Disease in India: Challenges and SolutionsNephron Clinical Practice, 2009
- Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patientsNephrology Dialysis Transplantation, 2009
- Diagnosis of tuberculosis infection in patients awaiting liver transplantationHuman Immunology, 2009
- Risk factors for Mycobacterium tuberculosis in US chronic dialysis patientsNephrology Dialysis Transplantation, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- THE HIGH INCIDENCE OF TUBERCULOSIS AMONG RENAL TRANSPLANT RECIPIENTS IN INDIATransplantation, 1996
- RAPID METABOLISM OF CYCLOSPORIN AND PREDNISONE IN KIDNEY TRANSPLANT PATIENT RECEIVING TUBERCULOSTATIC TREATMENTThe Lancet, 1983